Dr. Ravi Vijayvargia

Dr. Ravi Vijayvargia, Ph.D. is an accomplished molecular neurobiologist and biochemist, currently serving as Assistant Professor in the Department of Biochemistry at The Maharaja Sayajirao University of Baroda, India. With over a decade of academic service since 2013, he has played a pivotal role in shaping the university’s prestigious five-year Integrated M.Sc. programme in Cell and Molecular Biology, contributing both as a mentor and as Assistant Director. Dr. Vijayvargia completed his Ph.D. in Biotechnology from the National Centre for Cell Science (NCCS), Pune, under the mentorship of Dr. M. V. Krishnasastry. His postdoctoral research in the United States spans cancer biology and metabolic regulation at UMDNJ, and Huntington’s disease pathobiology at Massachusetts General Hospital and Harvard Medical School. His research primarily focuses on protein misfolding disorders, with emphasis on Huntington’s disease, neurodegeneration, and therapeutic modulation and immunoassay-based diagnosis. He has authored over 22 peer-reviewed publications, including a landmark eLife study on the full-length huntingtin protein structure and a recent Human Molecular Genetics paper on PKA-regulated turnover of huntingtin. As a principal investigator, Dr. Vijayvargia has secured more than ₹2 crore in competitive research funding from SERB, ICMR, DBT, and GSBTM. His contributions have been recognized with the NJCCR–CINJ Gallo Award and national fellowships from UGC–CSIR and DBT. Through his multidisciplinary expertise and translational vision, he continues to be a key contributor to the advancement of neurodegenerative disease and dignostics research in India.